These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19220169)

  • 21. Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.
    Murrie B; Lappin J; Large M; Sara G
    Schizophr Bull; 2020 Apr; 46(3):505-516. PubMed ID: 31618428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-mutilation and severe self-injurious behavior associated with amphetamine psychosis.
    Kratofil PH; Baberg HT; Dimsdale JE
    Gen Hosp Psychiatry; 1996 Mar; 18(2):117-20. PubMed ID: 8833581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adderall-induced psychosis in an adolescent.
    Surles LK; May HJ; Garry JP
    J Am Board Fam Pract; 2002; 15(6):498-500. PubMed ID: 12463297
    [No Abstract]   [Full Text] [Related]  

  • 24. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.
    Snyder SH
    Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 27. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
    Dalmau A; Bergman B; Brismar B
    Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Khat-induced psychosis?].
    Degraeve G
    Tijdschr Psychiatr; 2007; 49(10):763-7. PubMed ID: 17929229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provocative tests with psychostimulant drugs in schizophrenia.
    Lieberman JA; Kane JM; Alvir J
    Psychopharmacology (Berl); 1987; 91(4):415-33. PubMed ID: 2884687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.
    BELL DS
    Br J Psychiatry; 1965 Aug; 111():701-7. PubMed ID: 14337419
    [No Abstract]   [Full Text] [Related]  

  • 33. Khat induced psychosis and its medico-legal implication: a case report.
    Alem A; Shibre T
    Ethiop Med J; 1997 Apr; 35(2):137-9. PubMed ID: 9577014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosis associated with prescribed dexamphetamine use.
    Spear J; Alderton D
    Aust N Z J Psychiatry; 2003 Jun; 37(3):383. PubMed ID: 12780481
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
    Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G
    Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulant psychosis: systematic review.
    Curran C; Byrappa N; McBride A
    Br J Psychiatry; 2004 Sep; 185():196-204. PubMed ID: 15339823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isosafrole and schizophrenia-like psychosis.
    Keitner GI; Sabaawi M; Haier RJ
    Am J Psychiatry; 1984 Aug; 141(8):997-8. PubMed ID: 6465379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychostimulant use and the brain.
    Lappin JM; Sara GE
    Addiction; 2019 Nov; 114(11):2065-2077. PubMed ID: 31321819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs of abuse and increased risk of psychosis development.
    Gururajan A; Manning EE; Klug M; van den Buuse M
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1120-35. PubMed ID: 22833579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotic illness following 'mabi bark tea' consumption.
    Hassiotis A; Taylor J
    Br J Psychiatry; 1992 Sep; 161():404-7. PubMed ID: 1393313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.